Cargando…
Technical and safety performance of CT-guided percutaneous microwave ablation for lung tumors: an ablate and resect study
BACKGROUND: Percutaneous image-guided thermal ablation has an increasing role in the treatment of primary and metastatic lung tumors. Achieving acceptable clinical outcomes requires better tools for pre-procedure prediction of ablation zone size and shape. METHODS: This was a prospective, non-random...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743408/ https://www.ncbi.nlm.nih.gov/pubmed/35070367 http://dx.doi.org/10.21037/jtd-21-594 |
_version_ | 1784629897385213952 |
---|---|
author | Blackmon, Shanda H. Sterner, Rosalie M. Eiken, Patrick W. Vogl, Thomas J. Pua, Bradley B. Port, Jeffrey L. Dupuy, Damian E. Callstrom, Matthew R. |
author_facet | Blackmon, Shanda H. Sterner, Rosalie M. Eiken, Patrick W. Vogl, Thomas J. Pua, Bradley B. Port, Jeffrey L. Dupuy, Damian E. Callstrom, Matthew R. |
author_sort | Blackmon, Shanda H. |
collection | PubMed |
description | BACKGROUND: Percutaneous image-guided thermal ablation has an increasing role in the treatment of primary and metastatic lung tumors. Achieving acceptable clinical outcomes requires better tools for pre-procedure prediction of ablation zone size and shape. METHODS: This was a prospective, non-randomized, single-arm, multicenter study conducted by Medtronic (ClinicalTrials.gov ID: NCT02323854). Subjects scheduled for resection of metastatic or primary lung nodules underwent preoperative percutaneous microwave ablation. Ablation zones as measured via CT imaging following ablation immediately and before resection surgically versus predicted ablation zones as prescribed by the investigational system software were compared. This CT scan occurred after the ablation was finished but the antenna still in position. Time (minutes) from antenna placement to removal was 23.7±13.1 (n=14); median: 21.0 (range, 6.0 to 48.0). The definition of the secondary endpoint of complete ablation was 100% non-viable tumor cells based on nicotinamide adenine dinucleotide hydrogen (NADH) staining. Safety endpoints were type, incidence, and severity of adverse events. RESULTS: Fifteen patients (mean age 58.9 years; 67% male; 33% female) were enrolled in the study, 33.3% (5/15) with previous thoracic surgery, 73% (11/15) with metastasis, and 27% (4/15) with primary lung tumors. All underwent percutaneous microwave ablation followed by surgical resection the same day. Complete ablation was detected in 54.4% (6/11), incomplete ablation in 36.4% (4/11), and delayed necrosis in 9.1% (1/11). There were no device-related adverse events. Ablation zone volume was overestimated in all patients. CONCLUSIONS: Histological complete ablation was observed in 55% of subjects. CT scanning less than an hour after ablation and tissue shrinkage may account for the smaller zone of ablation observed compared to predicted by the investigational system software. |
format | Online Article Text |
id | pubmed-8743408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87434082022-01-21 Technical and safety performance of CT-guided percutaneous microwave ablation for lung tumors: an ablate and resect study Blackmon, Shanda H. Sterner, Rosalie M. Eiken, Patrick W. Vogl, Thomas J. Pua, Bradley B. Port, Jeffrey L. Dupuy, Damian E. Callstrom, Matthew R. J Thorac Dis Original Article BACKGROUND: Percutaneous image-guided thermal ablation has an increasing role in the treatment of primary and metastatic lung tumors. Achieving acceptable clinical outcomes requires better tools for pre-procedure prediction of ablation zone size and shape. METHODS: This was a prospective, non-randomized, single-arm, multicenter study conducted by Medtronic (ClinicalTrials.gov ID: NCT02323854). Subjects scheduled for resection of metastatic or primary lung nodules underwent preoperative percutaneous microwave ablation. Ablation zones as measured via CT imaging following ablation immediately and before resection surgically versus predicted ablation zones as prescribed by the investigational system software were compared. This CT scan occurred after the ablation was finished but the antenna still in position. Time (minutes) from antenna placement to removal was 23.7±13.1 (n=14); median: 21.0 (range, 6.0 to 48.0). The definition of the secondary endpoint of complete ablation was 100% non-viable tumor cells based on nicotinamide adenine dinucleotide hydrogen (NADH) staining. Safety endpoints were type, incidence, and severity of adverse events. RESULTS: Fifteen patients (mean age 58.9 years; 67% male; 33% female) were enrolled in the study, 33.3% (5/15) with previous thoracic surgery, 73% (11/15) with metastasis, and 27% (4/15) with primary lung tumors. All underwent percutaneous microwave ablation followed by surgical resection the same day. Complete ablation was detected in 54.4% (6/11), incomplete ablation in 36.4% (4/11), and delayed necrosis in 9.1% (1/11). There were no device-related adverse events. Ablation zone volume was overestimated in all patients. CONCLUSIONS: Histological complete ablation was observed in 55% of subjects. CT scanning less than an hour after ablation and tissue shrinkage may account for the smaller zone of ablation observed compared to predicted by the investigational system software. AME Publishing Company 2021-12 /pmc/articles/PMC8743408/ /pubmed/35070367 http://dx.doi.org/10.21037/jtd-21-594 Text en 2021 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Blackmon, Shanda H. Sterner, Rosalie M. Eiken, Patrick W. Vogl, Thomas J. Pua, Bradley B. Port, Jeffrey L. Dupuy, Damian E. Callstrom, Matthew R. Technical and safety performance of CT-guided percutaneous microwave ablation for lung tumors: an ablate and resect study |
title | Technical and safety performance of CT-guided percutaneous microwave ablation for lung tumors: an ablate and resect study |
title_full | Technical and safety performance of CT-guided percutaneous microwave ablation for lung tumors: an ablate and resect study |
title_fullStr | Technical and safety performance of CT-guided percutaneous microwave ablation for lung tumors: an ablate and resect study |
title_full_unstemmed | Technical and safety performance of CT-guided percutaneous microwave ablation for lung tumors: an ablate and resect study |
title_short | Technical and safety performance of CT-guided percutaneous microwave ablation for lung tumors: an ablate and resect study |
title_sort | technical and safety performance of ct-guided percutaneous microwave ablation for lung tumors: an ablate and resect study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743408/ https://www.ncbi.nlm.nih.gov/pubmed/35070367 http://dx.doi.org/10.21037/jtd-21-594 |
work_keys_str_mv | AT blackmonshandah technicalandsafetyperformanceofctguidedpercutaneousmicrowaveablationforlungtumorsanablateandresectstudy AT sternerrosaliem technicalandsafetyperformanceofctguidedpercutaneousmicrowaveablationforlungtumorsanablateandresectstudy AT eikenpatrickw technicalandsafetyperformanceofctguidedpercutaneousmicrowaveablationforlungtumorsanablateandresectstudy AT voglthomasj technicalandsafetyperformanceofctguidedpercutaneousmicrowaveablationforlungtumorsanablateandresectstudy AT puabradleyb technicalandsafetyperformanceofctguidedpercutaneousmicrowaveablationforlungtumorsanablateandresectstudy AT portjeffreyl technicalandsafetyperformanceofctguidedpercutaneousmicrowaveablationforlungtumorsanablateandresectstudy AT dupuydamiane technicalandsafetyperformanceofctguidedpercutaneousmicrowaveablationforlungtumorsanablateandresectstudy AT callstrommatthewr technicalandsafetyperformanceofctguidedpercutaneousmicrowaveablationforlungtumorsanablateandresectstudy |